Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy

International Journal of Cardiology

Volumn 222, Issue , 2016, Pages 133-134

  Bojarczuk, Joanna ^b   Josiak, Krystian ^a,b   Kasztura, Monika ^a   Kustrzycka Kratochwil, Dorota ^b   Nowak, Krzysztof ^b   Jagielski, Dariusz ^b   Banasiak, Waldemar ^b   Jankowska, Ewa Anita ^a,b   Ponikowski, Piotr ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

Cardiac resynchronization therapy; Heart failure; Iron deficiency

Indexed keywords

HEMOGLOBIN; FERRITIN; IRON;

ADULT; ANEMIA; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; DEFICIENCY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEART FAILURE, SYSTOLIC; HEART LEFT VENTRICLE FUNCTION; IRON METABOLISM DISORDERS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLAND; PROCEDURES; SEVERITY OF ILLNESS INDEX;

CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; FERRITINS; HEART FAILURE, SYSTOLIC; HEMOGLOBINS; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; POLAND; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84979902942     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.280     Document Type: Article

References (10)

1. [1] Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail., 2016 May 20, 10.1002/ejhf.592 Epub ahead of print.
2. [2] Ingwall, J.S., Energy metabolism in heart failure and remodeling. Cardiovasc. Res. 81 (2009), 412–419.
3. [3] Stugiewicz, M., Tkaczyszyn, M., Kasztura, M., et al. The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications. Eur. J. Heart Fail., 2016 Jan 21, 10.1002/ejhf.467 Epub ahead of print.
4. [4] Jankowska, E.A., Rozentryt, P., Witkowska, A., et al. Iron deficiency: an omnious sign in patients with systolic heart failure. Eur. Heart J. 31 (2010), 1872–1880.
5. [5] Anker, S.D., Comin-Colet, J., Filippatos, G., et al. FAIR-HF Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 261 (2009), 2436–2448.
6. [6] Jankowska, E.A., Malyszko, J., Ardehali, H., et al. Iron status in patients with chronic heart failure. Eur. Heart J. 34 (2013), 827–834.
7. [7] Koulaozidis, A., Said, E., Cotter, R., Saeed, A.A., Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J. Gastrointestin. Liver Dis. 18 (2009), 345–352.
8. [8] Maeder, M.T., Khammy, O., Dos Remedios, C., et al. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J. Am. Coll. Cardiol. 58 (2011), 474–480.
9. [9] Enjuanes, C., Bruguera, J., Grau, M., et al. Iron status in chronic heart failure: impact on symptoms, functional class and submaximal exercise capacity. Rev. Esp. Cardiol. 69 (2016), 247–255.
10. [10] Dong, F., Zhang, X., Culver, B., et al. Dietary iron deficiency induces ventricular dilatation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin. Sci. 109 (2005), 277–286.